𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Weight-based high- and low-dose ribavirin in combination with peginterferon α-2b therapy for genotype 2 chronic hepatitis C: A randomized trial

✍ Scribed by Tatehiro Kagawa; Sei-ichiro Kojima; Koichi Shiraishi; Shinji Takashimizu; Naruhiko Nagata; Hirokazu Shiozawa; Yasuhiro Nishizaki; Akihiko Ikeda; Yoshihiro Tei; Kazuhiro Atsukawa; Jun-ichiro Kamochi; Mitsuru Wasada; Makoto Numata; Yoshitaka Arase; Shunji Hirose; Takuji Yamada; Yasuo Hata; Norihito Watanabe; Toshio Morizane; Tetsuya Mine

Book ID
114943981
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
310 KB
Volume
42
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2b and weight-based o
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial
✍ Ira M. Jacobson; Robert S. Brown Jr; Bradley Freilich; Nezam Afdhal; Paul Y. Kwo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

Clifford A. Brass, 15 and the WIN-R Study Group This prospective, multicenter, community-based and academic-based, open-label, investigator-initiated, U.S. study evaluated efficacy and safety of pegylated interferon (PEG-IFN) alfa-2b plus a flat or weight-based dose of ribavirin (RBV) in adults with